Fig. 2From: A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemiaKaplan-Meier curves depicting patient survival and relapse since the start of induction. a Overall patient survival (n = 20). b Relapse-free survival (n = 14)Back to article page